Oral Delivery of Large Molecules

Investor

Overview

SEC Filing Details

Document Details

Form
3
Filing Date
Feb 8, 2022
Document Date
Jan 1, 2022
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Entera Bio Ltd.
Issuer
Entera Bio Ltd.
Filer
YAACOV-GARBELI DANA